Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Announces CFO Retirement and Successor
Summary
On July 23, 2025, Thermo Fisher Scientific Inc. announced that Stephen Williamson, Senior Vice President and Chief Financial Officer (CFO), will retire effective March 31, 2026. The Company's Board of Directors has appointed James R. Meyer, currently Vice President, Financial Operations, to succeed Williamson as Senior Vice President and CFO, effective March 1, 2026. Meyer has been with the company since 2009 and has held various finance roles of increasing responsibility.
Profitelligence Alerts
Get alerts for TMO
Be first to know when Thermo Fisher Scientific Inc. files with the SEC.
Filing Categories
Advertisement
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a world-leading biotechnology company that provides essential tools and services for life sciences, biotechnology, pharmaceutical, and healthcare industries. Renowned for its extensive portfolio, the company specializes in offering innovative laboratory products, analytical instruments, and software solutions critical for research, diagnostics, and clinical applications. Thermo Fisher enables scientists to perform complex experiments with cutting-edge technology, from DNA sequencing and cell analysis to clinical diagnostics and specialty chemicals. Serving a vast array of sectors, the company impacts fields such as diagnostics, genetic engineering, and environmental monitoring. Its strategic acquisitions and collaborations strengthen its market presence, making it a go-to partner for scientific advancements and innovation. With operations spanning over 50 countries, Thermo Fisher plays a pivotal role in driving scientific discovery and improving health outcomes globally.
Official SEC Documents
Advertisement